As of Wednesday, December 17, Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 13.10%, which has investors questioning if this is right time to sell.
The firings come one month after the company voluntarily pulled a drug from the market at the request of the Food and Drug ...
Takeda has joined BaseLaunch, a platform created to launch, fund, and build early biotech ventures developing cutting-edge ...
CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by ...
BASEL, Switzerland, Dec. 16, 2025 /PRNewswire/ -- BaseLaunch, a platform to launch, fund, and build early biotech ventures developing cutting-edge therapeutics, announced today Takeda has joined the ...
As of Tuesday, December 16, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 8.47%, which has investors ...
Recently, the Ministry of Health, Labour and Welfare of Japan has called for companies to develop this product following a request from the Japan Society of Obstetrics and Gynecology to address the ...
Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.
Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery success to DISCOFinancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback